ERBB2 and breast carcinoma: In particular, troponin T, creatin kinase-MB and human epidermal growth factor receptor 2 (HER-2) secretion were monitored, upon doxorubicin administration, to investigate the relationship between chemotherapy-induced cardiotoxicity and breast cancer progression, both in physiological and pathological cardiac conditions.